Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Promising phase I/II findings in NSCLC reported for INGN-201 at ASCO

May 20, 1998

Pharmacokinetics of capecitabine affected by food

May 20, 1998

C225 + radiotherapy produces 100% response rate in head and neck cancer

May 19, 1998

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

May 19, 1998

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

May 19, 1998

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

May 19, 1998

Mechanism of antitumor activity of clotrimazole identified

May 18, 1998

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

May 18, 1998

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...